Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
CALL
Coupang
CPNG
$27.5B
| $21.8M | ﹤0.01% |
1,157,300
-622,300
| -35% | -$12.2M |
|
2352
Fidelity High Yield Factor ETF
FDHY
$567M
| $21.8M | ﹤0.01% |
+450,000
| New | +$22.2M |
|
2353
Annaly Capital Management
NLY
$17.4B
| $21.8M | ﹤0.01% |
1,028,883
-12,334
| -1% | -$281K |
|
|
JCAP
2354
Jefferson Capital
JCAP
$1.26B
| $21.8M | ﹤0.01% |
1,131,598
+553,677
| +96% | +$11.7M |
|
2355
ACM Research
ACMR
$4.9B
| $21.7M | ﹤0.01% |
552,304
+190,716
| +53% | +$10.1M |
|
2356
Stock Yards Bancorp
SYBT
$2.57B
| $21.7M | ﹤0.01% |
327,598
+190,451
| +139% | +$12.7M |
|
|
SARO
2357
StandardAero Inc
SARO
$9.85B
| $21.7M | ﹤0.01% |
840,434
+399,590
| +91% | +$11.9M |
|
2358
State Street SPDR S&P Health Care Services ETF
XHS
$212M
| $21.7M | ﹤0.01% |
216,762
+101,208
| +88% | +$10.8M |
|
2359
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$425M
| $21.7M | ﹤0.01% |
219,931
+26,994
| +14% | +$2.7M |
|
2360
EPAM Systems
EPAM
$5.27B
| $21.6M | ﹤0.01% |
159,542
-154,662
| -49% | -$26.4M |
|
2361
Arcus Biosciences
RCUS
$3.45B
| $21.6M | ﹤0.01% |
999,786
-168,651
| -14% | -$3.64M |
|
2362
B&G Foods
BGS
$300M
| $21.6M | ﹤0.01% |
4,487,074
+780,030
| +21% | +$3.78M |
|
2363
Envista
NVST
$4.61B
| $21.6M | ﹤0.01% |
850,441
-162,521
| -16% | -$4.21M |
|
2364
Vontier
VNT
$4.52B
| $21.6M | ﹤0.01% |
607,980
+9,898
| +2% | +$381K |
|
2365
KB Financial Group
KB
$39.8B
| $21.5M | ﹤0.01% |
215,889
+40,784
| +23% | +$4.1M |
|
|
MRX
2366
Marex Group Limited Ordinary Shares
MRX
$4.62B
| $21.5M | ﹤0.01% |
482,108
+237,488
| +97% | +$9.38M |
|
2367
PUT
United Airlines
UAL
$39.3B
| $21.5M | ﹤0.01% |
233,300
+165,000
| +242% | +$17.3M |
|
2368
Open Text
OTEX
$6.07B
| $21.5M | ﹤0.01% |
964,621
-449,785
| -32% | -$11.7M |
|
2369
BioMarin Pharmaceuticals
BMRN
$12B
| $21.4M | ﹤0.01% |
379,596
-75,316
| -17% | -$4.39M |
|
2370
AGNC Investment
AGNC
$12.9B
| $21.4M | ﹤0.01% |
2,129,934
+1,182,824
| +125% | +$13.1M |
|
|
SEMR
2371
DELISTED
Semrush
SEMR
| $21.3M | ﹤0.01% |
1,782,171
-108,626
| -6% | -$1.29M |
|
2372
CALL
Datadog
DDOG
$91.9B
| $21.3M | ﹤0.01% |
180,200
-248,900
| -58% | -$30.7M |
|
2373
Mineralys Therapeutics
MLYS
$2.39B
| $21.3M | ﹤0.01% |
785,043
-665,890
| -46% | -$19.5M |
|
2374
Biohaven
BHVN
$2.12B
| $21.3M | ﹤0.01% |
2,513,181
+550,975
| +28% | +$6.03M |
|
2375
Aurinia Pharmaceuticals
AUPH
$1.95B
| $21.2M | ﹤0.01% |
1,433,508
+427,175
| +42% | +$6.24M |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.